REGABATIN Trademark

Trademark Overview


On Thursday, September 19, 2013, a trademark application was filed for REGABATIN with the United States Patent and Trademark Office. The USPTO has given the REGABATIN trademark a serial number of 86069359. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 16, 2021. This trademark is owned by IntelliPharmaCeutics Corp.. The REGABATIN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis

Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations
regabatin

General Information


Serial Number86069359
Word MarkREGABATIN
Filing DateThursday, September 19, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 16, 2021
Registration Number4603064
Registration DateTuesday, September 9, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2014

Trademark Statements


Goods and ServicesDrug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis
Goods and ServicesResearch and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 16, 2021
Primary Code005
First Use Anywhere DateMonday, November 4, 2013
First Use In Commerce DateMonday, November 4, 2013

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 16, 2021
Primary Code042
First Use Anywhere DateMonday, November 4, 2013
First Use In Commerce DateMonday, November 4, 2013

Trademark Owner History


Party NameIntelliPharmaCeutics Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9W5X2
CA

Party NameIntelliPharmaCeutics Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9W5X2
CA

Party NameIntelliPharmaCeutics Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9W5X2
CA

Trademark Events


Event DateEvent Description
Friday, April 16, 2021CANCELLED SEC. 8 (6-YR)
Monday, September 9, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 9, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, August 5, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 4, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 15, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, June 20, 2014USE AMENDMENT FILED
Tuesday, July 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 20, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, May 13, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 10, 2014ELECTRONIC RECORD REVIEW COMPLETE
Friday, January 10, 2014ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, December 30, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 30, 2013ASSIGNED TO EXAMINER
Thursday, September 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 23, 2013NEW APPLICATION ENTERED IN TRAM